06:53 AM EDT, 10/30/2024 (MT Newswires) -- GSK (GSK) reported Q3 core earnings Wednesday of 0.497 British pounds ($0.65) per share, down from 0.504 pounds a year earlier.

Analysts polled by Capital IQ expected 0.43 pounds.

Turnover, or sales, for the quarter ended Sept. 30 was 8.01 billion pounds, down from 8.15 billion pounds a year earlier.

Analysts surveyed by Capital IQ expected 8 billion pounds.

For 2024, the drug maker said it continues to expect core EPS to grow 10% to 12% and turnover to grow 7% to 9%.

Shares of the company were down almost 4% in recent Wednesday premarket activity.

Price: 36.75, Change: -1.42, Percent Change: -3.72